Human diseases associated with form and function of the Golgi complex

International Journal of Molecular Sciences

Volumn 14, Issue 9, 2013, Pages 18670-18681

  Bexiga, Mariana G ^a   Simpson, Jeremy C ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Disease; Golgi complex; Intracellular trafficking; Membrane traffic; Protein glycosylation

Indexed keywords

MYELIN; PROTEOLIPID PROTEIN 1; PROTEOME; RAB PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

CELL FUNCTION; CELL MIGRATION; CELL SHAPE; CELL STRUCTURE; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 2; DISEASE ASSOCIATION; DUCHENNE MUSCULAR DYSTROPHY; ENDOPLASMIC RETICULUM; GOLGI COMPLEX; HAPPY PUPPET SYNDROME; HUMAN; LIPID METABOLISM; LOSS OF FUNCTION MUTATION; MEMBRANE TRANSPORT; MOLECULAR PATHOLOGY; NONHUMAN; PARKINSON DISEASE; PELIZAEUS MERZBACHER DISEASE; PROTEIN FOLDING; PROTEIN GLYCOSYLATION; PROTEIN MODIFICATION; REVIEW;

GLYCOSYLATION; GOLGI APPARATUS; HUMANS; PROTEOME;

EID: 84884192614     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140918670     Document Type: Review

References (54)

1. Aridor, M.; Hannan, L.A. Traffic jam: A compendium of human diseases that affect intracellular transport processes. Traffic 2000, 1, 836-851.
2. Aridor, M.; Hannan, L.A. Traffic jams ii: An update of diseases of intracellular transport. Traffic 2002, 3, 781-790.
3. Klumperman, J. Architecture of the mammalian golgi. Cold Spring Harb. Perspect. Biol. 2011, 3, doi:10.1101/cshperspect.a005181.
4. Lowe, M. Structural organization of the golgi apparatus. Curr. Opin. Cell Biol. 2011, 23, 85-93.
5. Inoue, K. Plp1-related inherited dysmyelinating disorders: Pelizaeus-merzbacher disease and spastic paraplegia type 2. Neurogenetics 2005, 6, 1-16.
6. Numata, Y.; Morimura, T.; Nakamura, S.; Hirano, E.; Kure, S.; Goto, Y.I.; Inoue, K. Depletion of molecular chaperones from the endoplasmic reticulum and fragmentation of the golgi apparatus associated with pathogenesis in pelizaeus-merzbacher disease. J. Biol. Chem. 2013, 288, 7451-7466.
7. Ting, C.H.; Wen, H.L.; Liu, H.C.; Hsieh-Li, H.M.; Li, H.; Lin-Chao, S. The spinal muscular atrophy disease protein smn is linked to the golgi network. PLoS One 2012, 7, e51826.
8. Zhang, C.; Li, D.; Zhang, J.; Chen, X.; Huang, M.; Archacki, S.; Tian, Y.; Ren, W.; Mei, A.; Zhang, Q.; et al. Mutations in abcb6 cause dyschromatosis universalis hereditaria. J. Investig. Dermatol. 2013, 133, 2221-2228.
9. Presley, J.F.; Cole, N.B.; Schroer, T.A.; Hirschberg, K.; Zaal, K.J.; Lippincott-Schwartz, J. Er-to-golgi transport visualized in living cells. Nature 1997, 389, 81-85.
10. Cole, N.B.; Sciaky, N.; Marotta, A.; Song, J.; Lippincott-Schwartz, J. Golgi dispersal during microtubule disruption: Regeneration of golgi stacks at peripheral endoplasmic reticulum exit sites. Mol. Biol. Cell 1996, 7, 631-650.
11. Hirschberg, K.; Miller, C.M.; Ellenberg, J.; Presley, J.F.; Siggia, E.D.; Phair, R.D.; Lippincott-Schwartz, J. Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J. Cell Biol. 1998, 143, 1485-1503.
12. Rendon, W.O.; Martinez-Alonso, E.; Tomas, M.; Martinez-Martinez, N.; Martinez-Menarguez, J.A. Golgi fragmentation is rab and snare dependent in cellular models of parkinson's disease. Histochem. Cell Biol. 2013, 139, 671-684.
13. Cooper, A.A.; Gitler, A.D.; Cashikar, A.; Haynes, C.M.; Hill, K.J.; Bhullar, B.; Liu, K.; Xu, K.; Strathearn, K.E.; Liu, F. et al. Alpha-synuclein blocks er-golgi traffic and rab1 rescues neuron loss in parkinson's models. Science 2006, 313, 324-328.
14. Dupuis, N.; Lebon, S.; Kumar, M.; Drunat, S.; Graul-Neumann, L.M.; Gressens, P.; El Ghouzzi, V. A novel rab33b mutation in smith-mccort dysplasia. Hum. Mutat. 2013, 34, 283-286.
15. Singan, V.R.; Handzic, K.; Simpson, J.C. Quantitative image analysis approaches for probing rab gtpase localization and function in mammalian cells. Biochem. Soc. Trans. 2012, 40, 1389-1393.
16. Saito, K.; Murai, J.; Kajiho, H.; Kontani, K.; Kurosu, H.; Katada, T. A novel binding protein composed of homophilic tetramer exhibits unique properties for the small gtpase rab5. J. Biol. Chem. 2002, 277, 3412-3418.
17. Basel-Vanagaite, L.; Sarig, O.; Hershkovitz, D.; Fuchs-Telem, D.; Rapaport, D.; Gat, A.; Isman, G.; Shirazi, I.; Shohat, M.; Enk, C.D. et al. Rin2 deficiency results in macrocephaly, alopecia, cutis laxa, and scoliosis: Macs syndrome. Am. J. Hum. Genet. 2009, 85, 254-263.
18. Syx, D.; Malfait, F.; van Laer, L.; Hellemans, J.; Hermanns-Le, T.; Willaert, A.; Benmansour, A.; de Paepe, A.; Verloes, A. The rin2 syndrome: A new autosomal recessive connective tissue disorder caused by deficiency of ras and rab interactor 2 (rin2). Hum. Genet. 2010, 128, 79-88.
19. Simpson, J.C.; Joggerst, B.; Laketa, V.; Verissimo, F.; Cetin, C.; Erfle, H.; Bexiga, M.G.; Singan, V.R.; Heriche, J.K.; Neumann, B.; et al. Genome-wide rnai screening identifies human proteins with a regulatory function in the early secretory pathway. Nat. Cell Biol. 2012, 14, 764-774.
20. Chia, J.; Goh, G.; Racine, V.; Ng, S.; Kumar, P.; Bard, F. Rnai screening reveals a large signaling network controlling the golgi apparatus in human cells. Mol. Syst. Biol. 2012, 8, 629.
21. Foulquier, F.; Amyere, M.; Jaeken, J.; Zeevaert, R.; Schollen, E.; Race, V.; Bammens, R.; Morelle, W.; Rosnoblet, C.; Legrand, D. et al. Tmem165 deficiency causes a congenital disorder of glycosylation. Am. J. Hum. Genet. 2012, 91, 15-26.
22. Zeevaert, R.; de Zegher, F.; Sturiale, L.; Garozzo, D.; Smet, M.; Moens, M.; Matthijs, G.; Jaeken, J. Bone dysplasia as a key feature in three patients with a novel congenital disorder of glycosylation (cdg) type ii due to a deep intronic splice mutation in tmem165. JIMD Rep. 2013, 8, 145-152.
23. Rosnoblet, C.; Legrand, D.; Demaegd, D.; Hacine-Gherbi, H.; de Bettignies, G.; Bammens, R.; Borrego, C.; Duvet, S.; Morsomme, P.; Matthijs, G et al. Impact of disease-causing mutations on tmem165 subcellular localization, a recently identified protein involved in cdg-ii. Hum. Mol. Genet. 2013, 22, 2914-2928.
24. Ungar, D. Golgi linked protein glycosylation and associated diseases. Semin. Cell Dev. Biol. 2009, 20, 762-769.
25. Rosnoblet, C.; Peanne, R.; Legrand, D.; Foulquier, F. Glycosylation disorders of membrane trafficking. Glycoconj. J. 2013, 30, 23-31.
26. Miller, V.J.; Ungar, D. Re'cog'nition at the golgi. Traffic 2012, 13, 891-897.
27. Freeze, H.H.; Ng, B.G. Golgi glycosylation and human inherited diseases. Cold Spring Harb. Perspect. Biol. 2011, 3, a005371.
28. Percival, J.M.; Froehner, S.C. Golgi complex organization in skeletal muscle: A role for golgi-mediated glycosylation in muscular dystrophies? Traffic 2007, 8, 184-194.
29. Taupenot, L.; Harper, K.L.; O'Connor, D.T. Role of h+-atpase-mediated acidification in sorting and release of the regulated secretory protein chromogranin a: Evidence for a vesiculogenic function. J. Biol. Chem. 2005, 280, 3885-3897.
30. Condon, K.H.; Ho, J.; Robinson, C.G.; Hanus, C.; Ehlers, M.D. The angelman syndrome protein ube3a/e6ap is required for golgi acidification and surface protein sialylation. J. Neurosci. 2013, 33, 3799-3814.
31. Kornak, U.; Reynders, E.; Dimopoulou, A.; van Reeuwijk, J.; Fischer, B.; Rajab, A.; Budde, B.; Nurnberg, P.; Foulquier, F.; Lefeber, D. et al. Impaired glycosylation and cutis laxa caused by mutations in the vesicular h+-atpase subunit atp6v0a2. Nat. Genet. 2008, 40, 32-34.
32. Fischer, B.; Dimopoulou, A.; Egerer, J.; Gardeitchik, T.; Kidd, A.; Jost, D.; Kayserili, H.; Alanay, Y.; Tantcheva-Poor, I.; Mangold, E. et al. Further characterization of atp6v0a2-related autosomal recessive cutis laxa. Hum. Genet. 2012, 131, 1761-1773.
33. Hucthagowder, V.; Morava, E.; Kornak, U.; Lefeber, D.J.; Fischer, B.; Dimopoulou, A.; Aldinger, A.; Choi, J.; Davis, E.C.; Abuelo, D.N. et al. Loss-of-function mutations in atp6v0a2 impair vesicular trafficking, tropoelastin secretion and cell survival. Hum. Mol. Genet. 2009, 18, 2149-2165.
34. Coman, D.; Irving, M.; Kannu, P.; Jaeken, J.; Savarirayan, R. The skeletal manifestations of the congenital disorders of glycosylation. Clin. Genet. 2008, 73, 507-515.
35. Percival, J.M.; Gregorevic, P.; Odom, G.L.; Banks, G.B.; Chamberlain, J.S.; Froehner, S.C. Raav6-microdystrophin rescues aberrant golgi complex organization in mdx skeletal muscles. Traffic 2007, 8, 1424-1439.
36. Fairclough, R.J.; Wood, M.J.; Davies, K.E. Therapy for duchenne muscular dystrophy: Renewed optimism from genetic approaches. Nat. Rev. Genet. 2013, 14, 373-378.
37. Starr, T.; Sun, Y.; Wilkins, N.; Storrie, B. Rab33b and rab6 are functionally overlapping regulators of golgi homeostasis and trafficking. Traffic 2010, 11, 626-636.
38. Valsdottir, R.; Hashimoto, H.; Ashman, K.; Koda, T.; Storrie, B.; Nilsson, T. Identification of rabaptin-5, rabex-5, and gm130 as putative effectors of rab33b, a regulator of retrograde traffic between the golgi apparatus and er. FEBS Lett. 2001, 508, 201-209.
39. Itoh, T.; Fujita, N.; Kanno, E.; Yamamoto, A.; Yoshimori, T.; Fukuda, M. Golgi-resident small gtpase rab33b interacts with atg16l and modulates autophagosome formation. Molecular Biol. Cell 2008, 19, 2916-2925.
40. Fukuda, M.; Itoh, T. Direct link between atg protein and small gtpase rab: Atg16l functions as a potential rab33 effector in mammals. Autophagy 2008, 4, 824-826.
41. Alshammari, M.J.; Al-Otaibi, L.; Alkuraya, F.S. Mutation in rab33b, which encodes a regulator of retrograde golgi transport, defines a second dyggve-melchior-clausen locus. J. Med. Genet. 2012, 49, 455-461.
42. Paupe, V.; Gilbert, T.; Le Merrer, M.; Munnich, A.; Cormier-Daire, V.; El Ghouzzi, V. Recent advances in dyggve-melchior-clausen syndrome. Mol. Genet. Metab. 2004, 83, 51-59.
43. Cheng, H.; Ma, Y.; Ni, X.; Jiang, M.; Guo, L.; Ying, K.; Xie, Y.; Mao, Y. Isolation and characterization of a human novel rab (rab39b) gene. Cytogenet. Genome Res. 2002, 97, 72-75.
44. Giannandrea, M.; Bianchi, V.; Mignogna, M.L.; Sirri, A.; Carrabino, S.; D'Elia, E.; Vecellio, M.; Russo, S.; Cogliati, F.; Larizza, L. et al. Mutations in the small gtpase gene rab39b are responsible for x-linked mental retardation associated with autism, epilepsy, and macrocephaly. Am. J. Hum. Genet. 2010, 86, 185-195.
45. Hennies, H.C.; Kornak, U.; Zhang, H.; Egerer, J.; Zhang, X.; Seifert, W.; Kuhnisch, J.; Budde, B.; Natebus, M.; Brancati, F. et al. Gerodermia osteodysplastica is caused by mutations in scyl1bp1, a rab-6 interacting golgin. Nat. Genet. 2008, 40, 1410-1412.
46. Al-Dosari, M.; Alkuraya, F.S. A novel missense mutation in scyl1bp1 produces geroderma osteodysplastica phenotype indistinguishable from that caused by nullimorphic mutations. Am. J. Med. Genet. Part A 2009, 149A, 2093-2098.
47. Corbett, M.A.; Schwake, M.; Bahlo, M.; Dibbens, L.M.; Lin, M.; Gandolfo, L.C.; Vears, D.F.; O'Sullivan, J.D.; Robertson, T.; Bayly, M.A. et al. A mutation in the golgi qb-snare gene gosr2 causes progressive myoclonus epilepsy with early ataxia. Am. J. Hum. Genet. 2011, 88, 657-663.
48. Boisse Lomax, L.; Bayly, M.A.; Hjalgrim, H.; Moller, R.S.; Vlaar, A.M.; Aaberg, K.M.; Marquardt, I.; Gandolfo, L.C.; Willemsen, M.; Kamsteeg, E.J. et al. 'North sea' progressive myoclonus epilepsy: Phenotype of subjects with gosr2 mutation. Brain 2013, 136, 1146-1154.
49. Roussel, B.D.; Kruppa, A.J.; Miranda, E.; Crowther, D.C.; Lomas, D.A.; Marciniak, S.J. Endoplasmic reticulum dysfunction in neurological disease. Lancet Neurol. 2013, 12, 105-118.
50. Millott, R.; Dudek, E.; Michalak, M. The endoplasmic reticulum in cardiovascular health and disease. Can. J. Physiol. Pharmacol. 2012, 90, 1209-1217.
51. Platt, F.M.; Boland, B.; van der Spoel, A.C. The cell biology of disease: Lysosomal storage disorders: The cellular impact of lysosomal dysfunction. J. Cell Biol. 2012, 199, 723-734.
52. Tumer, Z. An overview and update of atp7a mutations leading to menkes disease and occipital horn syndrome. Hum. Mutat. 2013, 34, 417-429.
53. Huster, D.; Hoppert, M.; Lutsenko, S.; Zinke, J.; Lehmann, C.; Mossner, J.; Berr, F.; Caca, K. Defective cellular localization of mutant atp7b in wilson's disease patients and hepatoma cell lines. Gastroenterology 2003, 124, 335-345.
54. Egorov, M.V.; Capestrano, M.; Vorontsova, O.A.; Di Pentima, A.; Egorova, A.V.; Mariggio, S.; Ayala, M.I.; Tete, S.; Gorski, J.L.; Luini, A. et al. Faciogenital dysplasia protein (fgd1) regulates export of cargo proteins from the golgi complex via cdc42 activation. Mol. Biol. Cell 2009, 20, 2413-2427.